期刊文献+

载脂蛋白H基因多态性与冠心病关系的研究

Relationship between apolipoprotein H Gene polymorphism and coronary heart disease
下载PDF
导出
摘要 目的探讨载脂蛋白H(ApoH)外显子3、8基因多态性与冠心病(CHD)的关系。方法采用聚合酶链式反应结合限制性片段长度多态分析方法,分析了100例健康人及110例冠心病患者的ApoH外显子3、8基因型。结果CHD组外显3GG基因型的频率为81.8%,GA+AA基因型频率为11.8%,G等位基因频率为88%,A等位基因频率是12%,与对照组比较无差异,CHD组外显子8GG基因型频率为74.5%、GC基因型频率为25.5%,G等位基因频率为87%,C等位基因频率为13%,与对照组比较CHD组的GC基因型频率及C等位基因频率显著增高。结论ApoH外显子3基因多态性与CHD无相关性;8GC基因型及C等位基因与CHD有关。 Objective To investigate relationship between the polymorphism of apolipoprotein H(ApoH) exon3 and exon 8 polymorphismand coronary heart disease(CHD). Methods Polymerase chain reaction and technique of restriction fragment length polymorphism were used to determine the genotypes of Aport exon 3 and exon8 in 110 patients with CHD and 100 health control group. Results The genotype GG of Aport exon 3 in the CHD group was 81.8% , GA + AA genotype was only 11.8%, the frequency of G allele was 88%, while 12%in the A allele; there was no significant difference with the control groups The frequency of GG genotype in Aport exon 8 were 74.5 % ,GC genotype were25.5 %, the frequency of G allele was 87 % ; the frequency of GC genotype and C allele in CHD group were significant higher than that in control group. LDL level in CHD group was significant higher than that in control group(P〈0.05). Conclusion The polymorphism of the Aport exon3 have no relationship with CHD but the GC genotyp of Aport exon3 and C allele have close relation with CHD and serum TG level.
出处 《中国心血管杂志》 2006年第2期106-108,共3页 Chinese Journal of Cardiovascular Medicine
关键词 载脂蛋白H外显子3 8 基因多态性 冠心病 Apolipoprotein H exon3 and exon 8 Gene polymorphism Coronary heart disease
  • 相关文献

参考文献2

二级参考文献10

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 2Henrik O, Thomas E. Structure of the human beta2-glycoprotein I gene. Eur J Biochem, 1999, 259∶435-440.
  • 3Sheng Y, Sali A, Herzog H, et al. Site-directed mutagenesis of recombinant human beta 2-glycoprotein Ⅰ identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol, 1996,157∶3744-3751.
  • 4Francisca C, Gushiken. Polymorphism of beta 2-glycoprotein Ⅰ at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheumatism,1999,42∶1189-1193.
  • 5Kamboh MI, Manzi S, Mehdi H, et al. Genetic variation in apolipoprotein H affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrations in systemic lupus erythematosus. Lupus, 1999,8∶742-750.
  • 6Cardigan RA, Donohoe S, Purdy G, et al. The association of factor Ⅶa, factor ⅩⅡa and beta2-glycoprotein Ⅰ with triglyceride-rich lipoproteins in normolipidaemic subjects. Blood Coagul Fibrinolysis, 1998,9∶323-332.
  • 7Nakaya Y, Schaefer EJ, Brewer HB. Activation of human post heparin lipase by apolipoprotein H. Biochim Biophys Res Commun, 1980,95∶1168.
  • 8Cassader M,Ruiu G, Fambino R, et al. Influence of apolipoprotein H polymorphism on levels of triglyceroides. Atherosclerosis,1994,110∶45-48.
  • 9Sepehrinia B,Kamboh MI, Adams-Campbell LL, et al. Genetic studies of human apolipoprotein: role of the apolipoprotein H polymorphism irrelation to serum lipoprotein concentrations. Hum Genet,1989,82∶118-122.
  • 10Mehdi H,Aston CE, Sanghera DK, et al. Genetic variation in the apolipoprotein H gene affects plasma apolipoprotein H concentrations. Hum Genet, 1999, 105∶63-71.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部